Exploring META-DOB. To explore a different substance…

Names:
META-DOB
m-DOB
5-Br-2,4-DMA
5-Bromo-2,4-dimethoxyamphetamine
IUPAC name:
1-(5-Bromo-2,4-dimethoxyphenyl)propan-2-amine
124 · C11H16BrNO2 · 274.154
InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-9(12)11(15-3)6-10(8)14-2/h5-7H,4,13H2,1-3H3
YFSLPSITQIUFQK-UHFFFAOYSA-N This stereoisomer Any stereoisomer

Scorza, M; Carrau, C; Silveira, R; Zapata-Torres, G; Cassels, BK; Reyes-Parada, M. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives. Biochem. Pharmacol., 15 Dec 1997, 54 (12), 1361–1369. 697 kB. https://doi.org/10.1016/S0006-2952(97)00405-X #25 5Br-2,4-DMA

Domelsmith, LN; Eaton, TA; Houk, KN; Anderson, GM; Glennon, RA; Shulgin, AT; Castagnoli, N; Kollman, PA. Photoelectron spectra of psychotropic drugs. 6. Relationships between physical properties and pharmacological actions of amphetamine analogues. J. Med. Chem., 1 Jan 1981, 24 (12), 1414–1421. 963 kB. https://doi.org/10.1021/jm00144a009

Bailey, K; Gagné, D; Pike, R. Investigation and identification of the bromination products of dimethoxyamphetamines. J. Assoc. Off. Anal. Chem., 1 Jan 1976, 59 (5), 1162–1169. 1.9 MB.

Maher, HM; Awad, T; DeRuiter, J; Clark, CR. GC-MS and GC-IRD studies on brominated dimethoxyamphetamines: Regioisomers related to 4-Br-2,5-DMA (DOB). Drug Test. Analysis, 1 Aug 2012, 4 (7–8), 591–600. 1.5 MB. https://doi.org/10.1002/dta.409

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 243–333. 2.6 MB. https://doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Hyperlab. Hyperlab new compounds. 29 Sep 2014. 232 kB. Note: Contains links to hyperlab.info that require elevated access/karma to follow.

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 2003; pp 67–137. 6.3 MB.

Anderson, GM; Castagnoli, N; Kollman, PA. Quantitative structure-activity relationships in the 2,4,5-ring-substituted phenylisopropylamines. In QuaSAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. NIDA Research Monograph 22; Barnett, G; Trsic, M; Willette, RE, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1978; pp 199–217. 623 kB. #10

Shulgin, AT. Psychotomimetic agents. In Psychopharmacological Agents; Gordon, M, Ed., Academic Press, New York, 1976; Vol. 4, pp 59–146. 3.1 MB. #LXXXV

4,3,5-DOB · 4-Br-3,5-DMA
DOB
2C-B-2-EtO · 2CB-2ETO
N-Me-2-Br-DMPEA
ORTHO-DOB
5,2,3-DOB · 5-Br-2,3-DMA
6,2,3-DOB · 6-Br-2,3-DMA
3,2,6-DOB · 3-Br-2,6-DMA
2,3,5-DOB · 2-Br-3,5-DMA
4,2,6-DOB · ψ-DOB
2C-B-M
4,2,3-DOB
3,2,4-DOB
2,3,4-DOB
3-DOB
2C-B-5-EtO
3,4,5-DOB
2,3,6-DOB
2,4,6-DOB
BMB
24 September 2018 · Creative Commons BY-NC-SA ·